Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Eptifibatide Injection

Approval Number

国药准字H20184117

Company深圳翰宇药业股份有限公司

Registration Date

December 5, 2019

Drug Information

Generic Name

依替巴肽注射液

Trade Name

翰安

Dosage Form

注射剂

Strength

10ml∶20mg

Drug Type

化学药品

Registration Date

December 5, 2019

Company Information

Applicant Company

Company Name深圳翰宇药业股份有限公司

Company Address

深圳市南山高新区技术工业园区中区翰宇生物医药园办公大楼四层

Manufacturing Company

Company Name深圳翰宇药业股份有限公司

Company Address

深圳市坪山区坑梓金沙社区卢辉路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy